J&J: AI to Halve Drug Development Time
📊 GOOGL — Piyasa Yorumu
▲ up · 60%GOOGL shares recorded a strong 9.76% gain in the last 24 hours, closing at $383.24. The RSI stands at 67.7, approaching overbought territory but not yet signaling an overbought condition. The MACD line remains below the signal line but is in positive territory. Although the news headline is not directly related to GOOGL, the use of artificial intelligence in drug development could increase interest in Alphabet's AI capabilities. Short-term upward momentum is expected to continue, but caution is advised due to the risk of overbought conditions.
📊 JNJ — Piyasa Yorumu
■ neutral · 60%While the news is a positive development for J&J in the long term, it is not expected to directly affect the price in the short term. Technical indicators paint a weak picture: the RSI at 36 is near oversold territory, the MACD is below the signal line, and the price is below both the 20-day and 50-day moving averages. The 1.5% decline over the last 24 hours indicates continued selling pressure. Therefore, the positive impact of the news may not offset the technical weakness, and the price is likely to trade sideways in the short term.